Replies to post #200595 on Biotech Values

[DewDiligence]

Background re GILD-Nimbus deal from one of Nimbus’ VCs:

http://www.forbes.com/sites/brucebooth/2016/04/04/atlas-backed-nimbus-delivers-its-apollo-mission-a-1-2b-gilead-partnership/#6b835d3d7273

[dewophile]

FGEN

I bet if FGEN's CTGF targeted drug gets a positive read in ph 2 GILD will be among the first to line up to partner. it would get them back in the IPF scene in a serious way after their drug failed, and give them yet another target in NASH